Dr. Reddy's Laboratories
Editor's Note: The article has been modified to better describe the current companies' dividend arrangements.
Even a hardcore dividend addict such as I will admit that there are times when a company should hold off on paying a dividend. The following is an examination of a few companies in the drug manufacturing sector and my conclusions about their dividend arrangements. In short, should these companies continue to pay dividends more »
Established in 1970 by Bill Manning and Bill Napier, Manning & Napier is on of the largest fund management companies in the U.S. For more than four decades, Manning & Napier has been leading institutional and individual clients towards their financial goals. Manning and Napier have an opportunistic investment style. The management aims to assist investors to meet a broad range of investment requirements even in the most challenging environments. As more »
Dr. Reddy’s Laboratories (NYSE: RDY) is an India-based integrated global pharmaceutical company. RDY is one of the largest pharmaceutical companies in India, with revenue of $2 billion in FY 2012. The company focuses on three core businesses; Pharmaceutical Services and Active Ingredients, Global Generics, and Proprietary Products.
Pharmaceutical Services & Active Ingredients (PSAI)
Through the PSAI unit, RDY offers speedy product development with IP advantages, as well as cost effective more »